These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17878955)

  • 1. HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24.
    Borghans JA; Mølgaard A; de Boer RJ; Keşmir C
    PLoS One; 2007 Sep; 2(9):e920. PubMed ID: 17878955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.
    Saina MC; Bi X; Lihana R; Lwembe R; Ishizaki A; Panikulam A; Palakudy T; Musoke R; Owens M; Songok EM; Ichimura H
    PLoS One; 2015; 10(8):e0137140. PubMed ID: 26317223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection.
    Thobakgale CF; Prendergast A; Crawford H; Mkhwanazi N; Ramduth D; Reddy S; Molina C; Mncube Z; Leslie A; Prado J; Chonco F; Mphatshwe W; Tudor-Williams G; Jeena P; Blanckenberg N; Dong K; Kiepiela P; Coovadia H; Ndung'u T; Walker BD; Goulder PJ
    J Virol; 2009 Oct; 83(19):10234-44. PubMed ID: 19605475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
    Tsai MC; Singh S; Adland E; Goulder P
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
    Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
    J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High polymorphism rates in well-known T cell epitopes restricted by protective HLA alleles during HIV infection are associated with rapid disease progression in early-infected MSM in China.
    He C; Han X; Zhang H; Jiang F; An M; Zhao B; Ding H; Zhang Z; Dong T; Shang H
    Med Microbiol Immunol; 2019 Apr; 208(2):239-251. PubMed ID: 30848362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
    Dorrell L; Willcox BE; Jones EY; Gillespie G; Njai H; Sabally S; Jaye A; DeGleria K; Rostron T; Lepin E; McMichael A; Whittle H; Rowland-Jones S
    Eur J Immunol; 2001 Jun; 31(6):1747-56. PubMed ID: 11385619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.
    Zhai S; Zhuang Y; Song Y; Li S; Huang D; Kang W; Li X; Liao Q; Liu Y; Zhao Z; Lu Y; Sun Y
    Curr HIV Res; 2008 Jun; 6(4):335-50. PubMed ID: 18691032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles.
    Gudmundsdotter L; Bernasconi D; Hejdeman B; Sandstrom E; Alaeus A; Lidman K; Ensoli B; Wahren B; Buttò S
    Vaccine; 2008 Sep; 26(40):5182-7. PubMed ID: 18479789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression.
    Stewart-Jones GB; Gillespie G; Overton IM; Kaul R; Roche P; McMichael AJ; Rowland-Jones S; Jones EY
    J Immunol; 2005 Aug; 175(4):2459-68. PubMed ID: 16081817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved HIV-1 Gag p24 Epitopes Elicit Cellular Immune Responses That Impact Disease Outcome.
    Tarosso LF; Vieira VA; Sauer MM; Tomiyama HI; Kalil J; Kallas EG
    AIDS Res Hum Retroviruses; 2017 Aug; 33(8):832-842. PubMed ID: 28594230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
    Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
    Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles.
    Streeck H; Lichterfeld M; Alter G; Meier A; Teigen N; Yassine-Diab B; Sidhu HK; Little S; Kelleher A; Routy JP; Rosenberg ES; Sekaly RP; Walker BD; Altfeld M
    J Virol; 2007 Jul; 81(14):7725-31. PubMed ID: 17494064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
    Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Design and Immunologic Evaluation of HIV-1 p24-Nef Fusion Protein to Approach a Therapeutic Vaccine Candidate.
    Larijani MS; Sadat SM; Bolhassani A; Pouriayevali MH; Bahramali G; Ramezani A
    Curr HIV Res; 2018; 16(5):322-337. PubMed ID: 30605062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.
    French MA; Center RJ; Wilson KM; Fleyfel I; Fernandez S; Schorcht A; Stratov I; Kramski M; Kent SJ; Kelleher AD
    AIDS; 2013 Feb; 27(4):519-28. PubMed ID: 23364441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.
    Masemola AM; Mashishi TN; Khoury G; Bredell H; Paximadis M; Mathebula T; Barkhan D; Puren A; Vardas E; Colvin M; Zijenah L; Katzenstein D; Musonda R; Allen S; Kumwenda N; Taha T; Gray G; McIntyre J; Karim SA; Sheppard HW; Gray CM;
    J Immunol; 2004 Oct; 173(7):4607-17. PubMed ID: 15383595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.